Author

John Cameron Bell

Ottawa Hospital Research InstituteORCID 0000-0002-9083-357XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:mouse· 2 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alan A. MelcheriD· 2 shared Fiona Errington‐MaisiD· 2 shared Victoria A. JenningsiD· 2 shared Anton PatrikeeviD· 1 shared Carolina S. IlkowiD· 1 shared Christy RalphiD· 1 shared David JacksoniD· 1 shared Edward John Lloyd Armstrong· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alan A. MelcherORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhancing oncolytic virotherapy by exosome-mediated microRNA reprograming of the tumour microenvironment.

Victoria A. Jennings, Reah Rumbold-Hall, Gemma Migneco, Tyler Barr, Katrina Reilly, Nicola Ingram, Isabelle St Hilare, Samuel Heaton, Noura Alzamel, David Jackson, Christy Ralph, Susana N. Banerjee, Iain A. McNeish, John Cameron Bell, Alan A. Melcher, , Fiona Errington‐Mais

This study uses oncolytic viruses to deliver miRNA to TAMs, reversing their immunosuppressive activity and improving ovarian cancer immunotherapy efficacy.

Frontiers in Immunology · Dec 23, 2024Peer-reviewedCancer Biology

Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T cell receptor signalling.

Edward John Lloyd Armstrong, Matthew Kin-Liang Chiu, Shane Foo, Lizzie Appleton, Pablo Nenclares, Anton Patrikeev, Nitya Mohan, Martin Mclaughlin, Galabina Bozhanova, Julia Hoebart, Victoria Roulstone, Emmanuel Christian Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, , Victoria A. Jennings

This study shows that combining oncolytic Maraba virus with PD-1 blockade overcomes resistance in advanced melanoma with a cold tumor microenvironment.

Journal for ImmunoTherapy of Cancer · Jul 1, 2024Peer-reviewedCancer Biology